Unilife is a U.S-based medical device and technology company that designs, develops, manufactures and supplies innovative, differentiated delivery systems for injectable drugs, biologics and vaccines. Unilife has a broad portfolio of injectable drug delivery systems including prefilled syringes, auto-injectors, wearable injectors, drug reconstitution delivery systems, ocular delivery systems and novel devices. Unilife builds long-term partnerships with pharmaceutical and biotechnology companies seeking to leverage our products to enable, enhance and differentiate their injectable therapies. Unilife can develop or customize its device technologies to address the specific drug, commercial and patient needs of its pharmaceutical customers. Unilife’s dynamic business environment, advanced operational capabilities, world-class team and stringent quality processes enables the Company to serve the device innovation needs of its pharmaceutical customers with speed, agility and reliability. A state-of-the-art global headquarters and manufacturing facility in York, PA serves as an integrated center for the seamless design, development, production, quality control, regulatory compliance and commercial supply of its products.

Type
Public
HQ
York, US
Founded
2002
Size (employees)
160 (est)-30%
Unilife Corporation was founded in 2002 and is headquartered in York, US
Report incorrect company information

Key People/Management at Unilife Corporation

Alan D. Shortall

Alan D. Shortall

CEO
Ramin Mojdehbakhsh

Ramin Mojdehbakhsh

COO

Unilife Corporation Office Locations

Unilife Corporation has an office in York and King of Prussia
York, US (HQ)
250 Cross Farm Lane
King of Prussia, US
150 S Warner Rd
Show all (2)
Report incorrect company information

Unilife Corporation Financials and Metrics

Unilife Corporation Financials

Unilife Corporation's revenue was reported to be $14.84 m in FY, 2016 which is a 12.8% increase from the previous period.
USD

Revenue (FY, 2016)

14.8 m

Revenue growth (FY, 2015 - FY, 2016), %

12.8%

Net income (FY, 2016)

(100.8 m)

EBIT (FY, 2016)

(103.6 m)

Market capitalization (4-Apr-2017)

2.7 m

Closing share price (4-Apr-2017)

0.2

Cash (4-Feb-2018)

18.7 m

EV

(15.4 m)
Unilife Corporation's current market capitalization is $2.7 m.
Annual
USDFY, 2014FY, 2015FY, 2016

Revenue

14.7 m13.2 m14.8 m

Revenue growth, %

(10%)13%

General and administrative expense

27.9 m36.2 m43.2 m

R&D expense

34.1 m52.5 m43.2 m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Revenue

3.2 m3.6 m1.4 m1.4 m5.4 m2.9 m3.2 m4.5 m822 k1.7 m2.3 m

General and administrative expense

6.5 m6.7 m6.6 m8.2 m9.5 m9.1 m9.2 m8.8 m17.6 m8.2 m6.1 m

R&D expense

6.4 m7.8 m8 m11 m11.3 m13.2 m16 m10.5 m9.3 m6.8 m5.7 m

Operating expense total

14 m15.5 m15.7 m20.3 m22.1 m23.5 m26.8 m20.7 m55 m16.7 m12.8 m
Annual
USDFY, 2014FY, 2015FY, 2016

Cash

8.4 m12.3 m18.7 m

Accounts Receivable

1.9 m1.5 m374 k

Inventories

142 k151 k89 k

Current Assets

13.9 m17 m23.2 m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Cash

7.4 m4.3 m37.7 m4.2 m8.4 m37.1 m5.8 m18 m41.6 m6 m9.3 m

Accounts Receivable

5.1 m2.7 m1.6 m4.6 m4.2 m5.9 m1.4 m3 m218 k2.1 m2.9 m

Inventories

72 k55 k63 k147 k165 k137 k107 k122 k110 k88 k100 k

Current Assets

14.8 m9.9 m42 m12 m16.2 m46.2 m10.6 m25.9 m46.9 m11.3 m21.3 m
Annual
USDFY, 2014FY, 2015FY, 2016

Net Income

(57.9 m)(90.8 m)(100.8 m)

Depreciation and Amortization

4.1 m4.9 m5.5 m

Inventories

(71 k)(9 k)62 k

Accounts Payable

1.1 m431 k(1.2 m)
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Net Income

(11.2 m)(27.5 m)(42.6 m)(22.3 m)(41.6 m)(64.8 m)(25.9 m)(51.3 m)(93.1 m)(18 m)(33.3 m)

Depreciation and Amortization

1 m2 m3.1 m1.1 m2.4 m3.5 m1.5 m3 m4.5 m1.7 m2.7 m

Inventories

(1 k)16 k8 k(5 k)(23 k)5 k44 k29 k41 k1 k(11 k)

Accounts Payable

(705 k)(658 k)781 k2.6 m2.2 m843 k4.9 m6.7 m555 k880 k7 k
USDY, 2016

EV/EBIT

0.1 x

EV/CFO

0.7 x

Financial Leverage

-1 x
Show all financial metrics

Unilife Corporation Operating Metrics

FY, 2016

Patents Issued

280
Show all operating metrics
Report incorrect company information